- Venous Treatments for venous diseases including varicose veins, deep vein thrombosis (DVT), and chronic venous insufficiency are becoming essential components of vascular healthcare systems worldwide due to their rising incidence in aging populations and increasing risk factors such as obesity and sedentary lifestyles
- The escalating demand for venous disease therapies is primarily fueled by technological advancements in minimally invasive procedures, greater patient awareness, and the shift toward outpatient care solutions that offer faster recovery and reduced procedural risks
- North America dominated the venous diseases treatment market with the largest revenue share of 40.1% in 2024, driven by advanced healthcare infrastructure, a high patient pool, and strong adoption of endovenous techniques, especially in the U.S., where both private and public healthcare providers continue to invest in modern vascular care technologies
- Asia-Pacific is expected to be the fastest growing region in the venous diseases treatment market during the forecast period due to growing healthcare access, increasing awareness of vascular conditions, and the rising number of specialized clinics offering affordable treatment options
- The ablation devices segment dominated the venous diseases treatment market by product type with a market share of 30.5% in 2024, owing to its widespread adoption in radiofrequency and laser procedures for varicose and incompetent veins
